Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Bevacizumab Bevacizumab (Avastin ) is a humanized anti-VEGF monoclonal antibody approved in combination with chemotherapy for the treatment of several advanced solid cancers (Kazazi-Hyseni et al., 2010)
DSIP Regulation in the Peptides UK Market Regulatory information checked on 21 July 2026
You will need approximately 4 to 5 vials to complete the entire escalation schedule
This listing supplies the retatrutide vial together with commonly used laboratory consumables (bacteriostatic water and graduated syringes) as a single order for convenience
Continuous standalone KPV alongside GLOW produces the same four-peptide composition with more handling
US$ 22.34
US$ 29.81
US$ 27.47
US$ 26.56
US$ 27.62
US$ 23.23
US$ 22.45
US$ 21.40
US$ 23.60
US$ 26.52
